🇮🇳 India Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

Tatva Chintan Pharma Chem Limited TATVA NSEINFRA

Basic Materials · Specialty Chemicals · India
https://www.tatvachintan.com
Company Profile ↓
₹1,408.50
+47.36% 1Y
Mkt Cap₹3,294.77 Cr
P/E577.25
P/B4.17
Div. Yield0.08%
52W High₹1,588.70
52W Low₹927.13
Book Value₹334.20
EPS (TTM)₹2.44

Company Overview

Tatva Chintan Pharma Chem Limited engages in the manufacture and sale of specialty chemicals in India, Germany, the United States of America, China, Singapore, and internationally. It offers structure directing agents (SDAs); phase transfer catalysts (PTCs); electrolyte salts for super capacitor batteries; pharmaceutical and agrochemical intermediates, and other specialty chemicals (PASC); and brominated flame retardants. The company serves automotive, refinery, pharmaceutical, agrochemicals, paints and coatings, dyes and pigments, personal care, and flavors and fragrances sectors. Tatva Chintan Pharma Chem Limited was incorporated in 1996 and is headquartered in Vadodara, India.

Why Investors Should Care

Conservative Balance Sheet

Carries low leverage with a debt-to-equity ratio of 0.15.

Recent Developments

  • Mar 2026 Revenue of ₹505.86 Cr (+32.2% YoY); net profit ₹42.05 Cr.
  • Trailing 12 Months Year-on-year growth — revenue +32.2%, earnings +636.1%.
  • 5-Year Trend Long-term compounding — revenue CAGR 6.3%, profit CAGR -2.6%.

Growth & Price Performance

Compounded Sales Growth

5 Years:6.32%
1 Year:32.18%

Compounded Profit Growth

5 Years:-2.58%
1 Year:636.11%

Stock Price Performance

1 Year:+47.36%
6 Months:+10.95%
3 Months:+9.70%
1 Month:+19.37%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish
52-Week Range 73% of range
₹927.13 ₹1,588.70
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMAAbove
  • RSI (14)70.85 · Overbought
Price Performance
1M+19.37%
3M+9.70%
6M+10.95%
1Y+47.36%
Valuation vs Sector

P/E of 577.25 is above the sector median of 27.45 — pricier than peers.

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

NSE TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

No notable strengths flagged.

CONS

  • Trading at a high P/E of 577.2.
  • Earnings shrank at -2.6% CAGR over 5 years.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
577.25
Industry PE
27.45
Forward P/E
34.52
PEG Ratio
-
Book Value
₹334.20
Price to Book
4.17
P/S
6.43
EV/EBITDA
36.15
Dividend Yield
0.08%

Growth (CAGR)

Revenue 5Y
6.32%
Profit 5Y
-2.58%
Revenue (YoY)
32.18%
Earnings (YoY)
636.11%

Profitability & Returns

ROCE
7.57%
ROE
5.38%
ROA
4.19%
Profit Margin
8.31%
Op Margin
11.13%
Gross Margin
55.61%
EPS (Latest Qtr)
₹4.41
EPS (TTM)
₹2.44

Balance Sheet & Liquidity

Debt/Equity
0.15
Quick Ratio
0.72
Current Ratio
1.64
Debt
₹120.37 Cr
Total Assets
₹1,003.69 Cr
Current Assets
₹349.51 Cr
Working Capital
₹136.38 Cr

Ownership

Promoter Holding
74.16%
Chg in Prom Hold
2.14%
FII / Inst Holding
5.86%
Chg in FII Hold
0.00%

Financial Snapshot

Enterprise Value
₹3,294.77 Cr
Total Revenue (TTM)
₹505.86 Cr
EBITDA
₹96.71 Cr
Free Cash Flow
₹-82.28 Cr
Operating Cash Flow
₹31.49 Cr
Shares Outstanding
₹2.34 Cr
Gross Margin
55.61%
Payout Ratio
5.56%

Peer comparison

Peer companies in the same sector (Basic Materials).

#NameCMP ₹P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 TATVA Tatva Chintan Pharma Chem Limited NSEINFRA 1,408.50 577.25 ₹3,294.77 Cr 0.08% 7.57% 5.38% 6.32% -2.58%
2 ULTRACEMCO UltraTech Cement Limited NIFTY50NSEINFRA 11,659.00 56.84 ₹3.44 L Cr 0.66% 11.90% 10.66% 12.40% 17.26%
3 JSWSTEEL JSW Steel Limited NIFTY50NSEAIINFRA 1,244.70 86.92 ₹3.04 L Cr 0.57% 18.75% 22.30% 3.61% 75.28%
4 ASIANPAINT Asian Paints Limited NIFTY50NSEINFRA 2,675.50 59.31 ₹2.57 L Cr 1.03% 24.41% 20.24% 1.10% 1.75%
5 TATASTEEL Tata Steel Limited NIFTY50NSEAIINFRA 187.67 21.70 ₹2.34 L Cr 2.09% 11.32% 10.56% -1.59% 7.21%
6 HINDZINC Hindustan Zinc Limited NSEINFRA 532.50 16.26 ₹2.25 L Cr 3.91% 61.97% 61.13% 5.61% 9.58%
7 HINDALCO Hindalco Industries Limited NIFTY50NSEAIINFRA 963.55 16.01 ₹2.17 L Cr 0.52% 9.42% 9.80% 7.10% 9.87%
8 GRASIM Grasim Industries Limited NIFTY50NSEINFRA 3,133.10 56.45 ₹2.13 L Cr 0.31% 4.00% 4.80% 14.63% -10.06%
9 VAML Vedanta Aluminium Metal Limited NSEINFRA 452.95 inf ₹1.77 L Cr 0.00% 41.97% 49.39% - -46.32%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in INR.

Metric Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue 125.00 Cr114.00 Cr97.00 Cr84.00 Cr98.00 Cr105.00 Cr83.00 Cr86.00 Cr107.86 Cr116.86 Cr123.52 Cr131.33 Cr134.14 Cr
Cost of Revenue --------57.69 Cr58.35 Cr54.86 Cr55.15 Cr56.19 Cr
Gross Profit --------50.18 Cr58.52 Cr68.65 Cr76.19 Cr77.96 Cr
Operating Expenses 108.00 Cr93.00 Cr76.00 Cr73.00 Cr83.00 Cr93.00 Cr78.00 Cr79.00 Cr48.49 Cr50.16 Cr55.49 Cr59.77 Cr59.59 Cr
Operating Income 13.00 Cr15.00 Cr13.00 Cr4.00 Cr10.00 Cr6.00 Cr-1.00 Cr01.69 Cr8.36 Cr13.16 Cr16.42 Cr18.37 Cr
EBITDA 16.00 Cr21.00 Cr20.00 Cr11.00 Cr16.00 Cr13.00 Cr6.00 Cr7.00 Cr9.67 Cr18.48 Cr23.22 Cr27.22 Cr27.78 Cr
Interest Expense 3.00 Cr3.00 Cr3.00 Cr0000038.80 L41.30 L50.70 L49.30 L1.44 Cr
Pretax Income 8.00 Cr13.00 Cr11.00 Cr5.00 Cr14.00 Cr7.00 Cr-1.00 Cr-02.03 Cr9.10 Cr13.66 Cr17.66 Cr16.59 Cr
Tax Provision -9.36 Cr3.77 Cr3.41 Cr1.70 Cr4.20 Cr1.68 Cr34.00 L099.70 L2.45 Cr3.75 Cr2.49 Cr6.27 Cr
Net Income 17.00 Cr10.00 Cr8.00 Cr3.00 Cr10.00 Cr5.00 Cr-1.00 Cr01.03 Cr6.65 Cr9.92 Cr15.16 Cr10.32 Cr
Diluted EPS 7.654.293.331.484.112.23-0.280.060.442.844.246.494.41

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue 136.00 Cr206.00 Cr263.00 Cr300.00 Cr-420.89 Cr390.50 Cr382.71 Cr505.86 Cr
Cost of Revenue -----234.59 Cr182.79 Cr198.94 Cr224.54 Cr
Gross Profit -----186.30 Cr207.70 Cr183.77 Cr281.32 Cr
Operating Expenses 113.00 Cr172.00 Cr208.00 Cr234.00 Cr-127.56 Cr163.58 Cr177.22 Cr225.01 Cr
Operating Income 20.00 Cr30.00 Cr50.00 Cr60.00 Cr-58.73 Cr44.12 Cr6.55 Cr56.31 Cr
EBITDA 23.00 Cr34.00 Cr55.00 Cr67.00 Cr-62.33 Cr75.32 Cr36.53 Cr96.71 Cr
Interest Expense 3.00 Cr4.00 Cr4.00 Cr4.00 Cr-8.00 Cr6.15 Cr1.29 Cr2.85 Cr
Pretax Income 19.00 Cr27.00 Cr48.00 Cr61.00 Cr-44.78 Cr43.57 Cr7.58 Cr57.01 Cr
Tax Provision 6.65 Cr6.75 Cr10.08 Cr8.54 Cr--70.80 L13.21 Cr1.87 Cr14.96 Cr
Net Income 12.00 Cr21.00 Cr38.00 Cr52.00 Cr-45.49 Cr30.35 Cr5.71 Cr42.05 Cr
Diluted EPS 15.3025.5647.0326.0244.5920.5213.262.44-

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets 144.00 Cr188.00 Cr249.00 Cr315.00 Cr-758.86 Cr818.72 Cr836.25 Cr1,003.69 Cr
Current Assets -----312.25 Cr297.91 Cr265.25 Cr349.51 Cr
Cash & Equivalents -----27.36 Cr35.30 Cr11.37 Cr5.76 Cr
Inventory -----162.50 Cr152.77 Cr133.95 Cr196.07 Cr
Receivables -----84.40 Cr69.85 Cr82.53 Cr119.03 Cr
Total Liabilities -----244.07 Cr81.64 Cr97.42 Cr221.94 Cr
Current Liabilities -----238.69 Cr79.66 Cr96.03 Cr213.13 Cr
Long Term Debt -----4.23 Cr63.90 L05.01 Cr
Total Debt 56.00 Cr77.00 Cr91.00 Cr90.00 Cr-170.26 Cr14.27 Cr36.39 Cr120.37 Cr
Total Equity 59.00 Cr80.00 Cr118.00 Cr166.00 Cr-514.79 Cr737.08 Cr738.82 Cr781.76 Cr
Shares Outstanding -----2.22 Cr2.34 Cr2.34 Cr2.34 Cr

Cash Flows (Annual)

Figures in INR.

Metric Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow 13.00 Cr7.00 Cr25.00 Cr20.00 Cr-27.78 Cr98.04 Cr24.77 Cr31.49 Cr
Investing Cash Flow -30.00 Cr-17.00 Cr-40.00 Cr-21.00 Cr--101.14 Cr-120.54 Cr-65.38 Cr-115.84 Cr
Financing Cash Flow 7.00 Cr17.00 Cr10.00 Cr-5.00 Cr-37.80 Cr30.52 Cr16.59 Cr78.93 Cr
Capital Expenditure -31.00 Cr-9.00 Cr-48.00 Cr-21.00 Cr--203.11 Cr-128.51 Cr-76.27 Cr-113.77 Cr
Free Cash Flow -18.00 Cr-2.00 Cr-23.00 Cr-1.00 Cr--175.33 Cr-30.47 Cr-51.50 Cr-82.28 Cr
Net Change in Cash -10.00 Cr8.00 Cr-5.00 Cr-6.00 Cr--35.57 Cr8.02 Cr-24.02 Cr-5.42 Cr

Ratios (Annual)

Figures in %.

Metric Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % -----44.3%53.2%48.0%55.6%
Operating Margin % 14.7%14.6%19.0%20.0%-14.0%11.3%1.7%11.1%
Net Margin % 8.8%10.2%14.4%17.3%-10.8%7.8%1.5%8.3%
ROE % 20.3%26.2%32.2%31.3%-8.8%4.1%0.8%5.4%
ROCE % -----11.3%6.0%0.9%7.1%

Shareholding Pattern

Insiders
74.16%
Institutions
5.86%
Public Float
22.69%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for TATVA

Google News Fri, 10 Jul 2026

Tatva chintan pharma faces sell rating as technical and growth hurdles outweigh recent gains - Indiatimes

<a href="https://news.google.com/rss/articles/CBMihAJBVV95cUxOUno3YVFOMUVyMFFlZTBnbFdDTy1jQkVYVFZBVkVMbXRnQk1aNTdwSnB2eGhEUGZBYlc4bnp6SU8ybFBfcmZncVVibmZvbVBCeVZiRjFnX3c5cHg2SUE1bXNHNVFpQ3Ryb2x6RTl6b242VEhXcGxnSml2Yl9XSlRRNS1WZTc2ZmYwMzE0bD…

Google News Mon, 18 May 2026

Earnings Update: Here's Why Analysts Just Lifted Their Tatva Chintan Pharma Chem Limited (NSE:TATVA) Price Target To ₹1,390 - simplywall.st

<a href="https://news.google.com/rss/articles/CBMi5AFBVV95cUxOMUMxM0xCalFheVEzZHZXUUxFbEZZaGZzdzNNYnZEd2ZkZXJNeVJHTW1XS01pVnd6dWl2eFNVM0ZLc0s1UmQ5UElwbmRmRm5NaElnaEg2V1Y5YjgySzlEeXNrbkdRTXl1QWlqQWlwenNITHlQTUVlYVM4Q0pUc1hEdFcwS3hpMUVrdnA5Yl…

Google News ue, 04 Nov 2025

Mukul Agrawal portfolio: What's driving Tatva Chintan to zoom 50% in 1 mth - Business Standard

<a href="https://news.google.com/rss/articles/CBMi1wFBVV95cUxQTzR0XzlXUTFVQjgxdDNxYlpfTU5JTHlja3VOM21YdFVmc29sU2xIb3ZjZVgwcktocTZDd0JKdVp6V1JYc0hQWHVrSUt0TEJhMUVBdHhDYjM2a0pZQks0OHR5WHl4UXlWRFhuLUljM0xQSS1mN0RyM2duZk5rS1kzT0xnY0MzS09ra252NH…

Google News ue, 19 May 2026

Tatva Chintan Promoters Declare No Share Encumbrance for FY26 - scanx.trade

<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxPY0tRcC1FcVZjUDB4UkUtZ2k4NjZVbVZaRWQ4QTFDeHNwdUNHU0pKQ01xaDJTdDBkOWF4clVYVzlzTENNcy1SV0RuYnRxOU5HRTlLNEhxWHRFLXo3ZUwzLVVKOGZhRXBmRkhMNmxvaF9ORGdXR2h4NGtHVThNSWptQzJNYi04eHhOOWd0VG…

Google News Sat, 16 May 2026

Tatva Chintan Q4 Net Profit Surges 10x to ₹10.3 Cr; Revenue Rises 18% to ₹130 Cr - Sahi

<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxOX1poUnhZSTVPSGdvMFlWLXNmdnJsTVRkN3VJV2hFSHZES2s3aXcwaGczcUJOMEY5bEM1SXQ2ejB4Y01QSDNIaV9yRXZwTmFMRFlyWkdYYVdqdDZqcC1IWEoteS1FQ3ZyREFIX3hXUmZGSk44RTd5M0Y3REF2ZkhGWFJpdnJvYTI5cTR5NF…

Google News Sat, 07 Mar 2026

Mukul Agrawal’s winning picks: 4 stocks turn multibaggers in FY26; fresh Q3 additions revealed - The Economic Times

<a href="https://news.google.com/rss/articles/CBMimAJBVV95cUxPZy1sSUx3OWNEdXYwM3NhQ0stNmhTN2psdFVBMmNGcjNYTm9CcmhPNmhuUzJFbC01cThqUDdURVkwRDQyOHQ5TlQzUkcxaXU0WjkwM25uSDhqZ2d0MkRodW5DbGtMRFo2ODRnb3VmcjcyX3k2VFpvcjdEa1ItV1B6d0E1Z1QwS3l5NEZ6QX…

TATVA — Frequently Asked Questions

What is the current share price of Tatva Chintan Pharma Chem Limited (TATVA)?

As of 2026-07-15 09:52 IST, Tatva Chintan Pharma Chem Limited (TATVA) trades at ₹1,408.50 on NSE. Its 52-week range is ₹927.13 to ₹1,588.70.

What is the market capitalisation of TATVA?

Tatva Chintan Pharma Chem Limited (TATVA) has a market capitalisation of ₹3,294.77 Cr on NSE.

What is the P/E ratio of TATVA?

TATVA trades at a trailing price-to-earnings (P/E) ratio of 577.25. The industry average P/E is 27.45. Its price-to-book (P/B) ratio is 4.17.

Does TATVA pay a dividend?

Tatva Chintan Pharma Chem Limited (TATVA) currently offers a dividend yield of 0.08%.

What is the return on equity (ROE) of TATVA?

TATVA has a return on equity (ROE) of 5.38%. Its return on capital employed (ROCE) is 7.57%.

Is TATVA a good stock to buy?

This page provides a data-driven analysis of Tatva Chintan Pharma Chem Limited (TATVA), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Basic Materials Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks
⚙Ad space